The project titled “Molecular-Level Investigation of the Synergistic Effects of Melittin- and Doxorubicin-Loaded Polymeric Nanoparticles on Triple-Negative Breast Cancer,” led by Berrin CHATZI MEMET from the ERU Department of Biomedical Engineering of the Institute of Science, has been awarded funding by TÜBİTAK under the TUBİTAK 1002-A Short-term Support Module. The project team includes Assoc. Prof. Ömer AYDIN from ERU Department of Biomedical Engineering as a advisor and Prof. Dr. Zuhal HAMURCU from Genome and Stem Cell Center as a researcher.

Congratulations to our researchers, and we wish them continued success.